Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString to Present at the 2019 Morgan Stanley Global Healthcare Conference
SEATTLE , Aug. 28, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 2019 Morgan Stanley Global
View HTML
Toggle Summary NanoString to Present at the Baird 2019 Global Healthcare Conference
SEATTLE , Aug. 19, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Baird 2019 Global Healthcare
View HTML
Toggle Summary New Publication Demonstrates First Use of NanoString’s GeoMx Digital Spatial Profiler in Neuroscience
Study Applies Digital Spatial Profiling and nCounter Gene Expression Panels to Illuminate Role of Immune System in Human Alzheimer’s Disease SEATTLE , Aug. 06, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and
View HTML
Toggle Summary NanoString Technologies Releases Operating Results for Second Quarter of 2019
SEATTLE , July 31, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the second quarter of 2019. Second Quarter Financial Highlights Total product
View HTML
Toggle Summary NanoString Technologies and Mayo Clinic Laboratories Enter Joint Development Agreement to Develop Novel Assays
SEATTLE and ROCHESTER, Minn. , July 30, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies and Mayo Clinic Laboratories have announced a collaboration to develop clinical tests using NanoString's new GeoMx Digital Spatial Profiler. GeoMx combines spatial and molecular profiling technologies by
View HTML
Toggle Summary Nature Medicine Publication Highlights use of the GeoMx Digital Spatial Profiler to Characterize Mechanism of Neurotoxicity in Immuno-Therapy
Third Nature Medicine Publication to Include Novel Discoveries Using Digital Spatial Profiling, Sixth Peer-Reviewed Publication to Date SEATTLE , July 23, 2019 (GLOBE NEWSWIRE) -- In a release issued yesterday by  NanoString Technologies, Inc. (NASDAQ:NSTG) under the same headline, please note that
View HTML
Toggle Summary NanoString Collaborates with MODEL-AD Consortium to Accelerate Alzheimer’s Disease Research
nCounter Mouse AD Gene Expression Panel Applied to Characterize Five Novel Mouse Models New nCounter Human AD Gene Expression Panel Launched at AAIC 2019 SEATTLE , July 15, 2019 (GLOBE NEWSWIRE) --   NanoString Technologies, Inc.  (NASDAQ:NSTG), a provider of life science tools for translational
View HTML
Toggle Summary NanoString to Release Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, July 31, 2019
SEATTLE , July 10, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release second quarter 2019 financial results after the close of trading on
View HTML
Toggle Summary Publication in the Journal for Clinical Cancer Research Uses NanoString’s GeoMx™ Digital Spatial Profiler to Discover Predictive Biomarkers for Immunotherapy
Researchers Used GeoMx Digital Spatial Profiler to Identify Biomarkers Predictive for Objective Response, Progression Free Survival and Overall Survival for Melanoma Patients Receiving Immunotherapy SEATTLE , June 18, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc.
View HTML
Toggle Summary NanoString Partners with Multiple Leading Contract Research Organizations to Provide Standardized PanCancer IO 360 Data Analysis Reports
Program Extends Ability of CAP CLIA Labs to Develop a Tumor Inflammation Signature Assay to Support Translational Research by Biopharmaceutical Companies SEATTLE , May 30, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for
View HTML